MoneyWorks4Me

Orchid Pharma - Quaterly Results

12 Feb 2025 Evaluate
Revenue reduced marginally to stand at Rs. 2173.43 millions during the quarter ended December 2024. The figure stood at Rs. 2205.91 millions during the year-ago period.Net profit declined -21.73% to Rs. 239.07 millions from Rs. 305.45 millions.The Operating Profit of the company witnessed a decrease to 363.03 millions from 433.51 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 2173.43 2205.91 -1.47 6844.48 6022.66 13.65 8193.68 6658.98 23.05
Other Income 99.37 74.36 33.63 256.72 175.04 46.66 303.89 194.30 56.40
PBIDT 363.03 433.51 -16.26 1148.71 992.60 15.73 1410.70 1030.49 36.90
Interest 37.91 35.37 7.18 105.60 128.80 -18.01 163.28 322.26 -49.33
PBDT 325.12 398.14 -18.34 1043.11 863.80 20.76 1247.42 1100.33 13.37
Depreciation 86.05 92.69 -7.16 256.74 248.18 3.45 332.19 547.87 -39.37
PBT 239.07 305.45 -21.73 786.37 615.62 27.74 915.23 552.46 65.66
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -32.26 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -32.26 0.00 0.00
PAT 239.07 305.45 -21.73 786.37 615.62 27.74 947.49 552.46 71.50
Equity 507.19 507.19 0.00 507.19 507.19 0.00 507.19 408.16 24.26
PBIDTM(%) 16.70 19.65 -15.01 16.78 16.48 1.83 17.22 15.48 11.25
Peers
Company Name CMP
Sun Pharma. Inds. 1851.50
Dr. Reddys Labs. 1140.50
Cipla 1357.95
Lupin 2041.60
Zydus Lifesciences 1098.40
View more..